洁特生物(688026) - 2024 Q4 - 年度业绩预告

Financial Projections - The company expects to achieve an annual revenue of 560 million yuan in 2024, an increase of 96.9 million yuan, representing a year-on-year growth of 20.92%[3] - The projected net profit attributable to the parent company for 2024 is 70 million yuan, an increase of 35.2 million yuan, reflecting a year-on-year growth of 101.22%[3] - The net profit attributable to the parent company after deducting non-recurring gains and losses is expected to be 63 million yuan, an increase of 31.2 million yuan, with a year-on-year growth of 98.21%[3] Cost Management and Profitability - The company has implemented cost control measures for raw materials and optimized internal management to reduce production costs, resulting in a significant increase in gross profit margin[6] Market Strategy - The company is focusing on expanding its product range and series while maintaining stable product prices in both domestic and international markets[6] - The company is actively developing new customers and maintaining relationships with existing clients through the establishment of its own brand sales team overseas[6] - The performance of the company's main business has been strong, with a continuous increase in market share contributing to the revenue growth[6] Financial Caution - The financial data provided is preliminary and has not been audited by registered accountants, and investors are advised to be cautious[7][8]